2016
DOI: 10.1016/j.jdcr.2016.09.001
|View full text |Cite
|
Sign up to set email alerts
|

Primary cutaneous cryptococcal infection with subsequent erythema nodosum in a 10-year-old immunocompetent girl

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
5
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(5 citation statements)
references
References 5 publications
0
5
0
Order By: Relevance
“…In the year 1972, Noble and Fajardo [ 10 ] proposed three diagnostic criteria for PCC (Table 1 ). We recorded the features of both our case and the 21 additional cases of PCC in immunocompetent patients due to C. neoformans in the last 20 years [ 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 ]. We excluded cases of PCC due to C. gattii , which is well known to be a cause of infection of immunocompetent patients in endemic areas [ 1 ].…”
Section: Discussionmentioning
confidence: 99%
“…In the year 1972, Noble and Fajardo [ 10 ] proposed three diagnostic criteria for PCC (Table 1 ). We recorded the features of both our case and the 21 additional cases of PCC in immunocompetent patients due to C. neoformans in the last 20 years [ 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 ]. We excluded cases of PCC due to C. gattii , which is well known to be a cause of infection of immunocompetent patients in endemic areas [ 1 ].…”
Section: Discussionmentioning
confidence: 99%
“…
Cryptococcosis is a fungal infection caused by Cryptococcus species, most commonly in immunocompromised individuals, especially in patients with HIV, organ transplant, and cancer chemotherapy. [1][2][3][4] The infection is relatively uncommon in immunocompetent patients in the absence of immunosuppression. Thus, cryptococcosis might be overlooked in immunocompetent individuals, which can lead to delayed diagnosis and treatment, and in some cases, fatal outcome.
…”
mentioning
confidence: 99%
“…Treatment options for immunocompetent patients range from a clinical observation to an antimycotic therapy, or to a surgical debridement. In PCC cases, the Infectious Disease Society of America guidelines recommended fluconazole 400 mg, orally, every day, for 6–12 months (Perfect et al, ), but therapeutic regimens are different, according to the situation (Hyde et al, ; Park et al, ; Posada et al, ).…”
mentioning
confidence: 99%
“…To the best of our knowledge, in the literature, there are less than 40 PCC cases about immunocompetent patients (Hyde et al, ). In our case, we observed clinical healing after 4 weeks of antifungal therapy, and we suppose that a healthy immune system could help the resolution of limited PCC infections, such as those reported by other authors (Du et al, ; Hyde et al, ).…”
mentioning
confidence: 99%
See 1 more Smart Citation